Design Therapeutics
DSGN
#7170
Rank
โ‚ฌ0.52 B
Marketcap
8,22ย โ‚ฌ
Share price
-3.22%
Change (1 day)
13.41%
Change (1 year)

EPS for Design Therapeutics (DSGN)

EPS in 2026 (TTM): -1,04ย โ‚ฌ

According to Design Therapeutics's latest financial reports the company's current EPS (TTM) is -1,09ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,11ย โ‚ฌ a decrease over its 2024 EPS that were of -0,80ย โ‚ฌ.

EPS history for Design Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,04ย โ‚ฌ-6.19%
2025-1,11ย โ‚ฌ38.64%
2024-0,80ย โ‚ฌ
2022-1,04ย โ‚ฌ32.56%
2021-0,78ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 12.50%๐Ÿ‡บ๐Ÿ‡ธ USA